Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis.
di Nuzzo, Luigi
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis. [electronic resource] - Drug design, development and therapy 2014 - 555-68 p. digital
Publication Type: Journal Article; Review
1177-8881
10.2147/DDDT.S52428 doi
Administration, Oral
Animals
Blood-Brain Barrier--drug effects
Crotonates--pharmacology
Dimethyl Fumarate
Fingolimod Hydrochloride
Fumarates--pharmacology
Humans
Hydroxybutyrates
Immune System--drug effects
Multiple Sclerosis--drug therapy
NF-E2-Related Factor 2--physiology
Nitriles
Propylene Glycols--pharmacology
Quinolones--pharmacology
Sphingosine--analogs & derivatives
Toluidines--pharmacology
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis. [electronic resource] - Drug design, development and therapy 2014 - 555-68 p. digital
Publication Type: Journal Article; Review
1177-8881
10.2147/DDDT.S52428 doi
Administration, Oral
Animals
Blood-Brain Barrier--drug effects
Crotonates--pharmacology
Dimethyl Fumarate
Fingolimod Hydrochloride
Fumarates--pharmacology
Humans
Hydroxybutyrates
Immune System--drug effects
Multiple Sclerosis--drug therapy
NF-E2-Related Factor 2--physiology
Nitriles
Propylene Glycols--pharmacology
Quinolones--pharmacology
Sphingosine--analogs & derivatives
Toluidines--pharmacology